CJC – 1295 NO DAC 5mg

Product Overview:

CJC-1295 Without DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH), based on the GHRH (1–29) peptide sequence.

It has been investigated in research involving GHRH receptor activity, endocrine signalling and the regulation of growth hormone-associated pathways.

The peptide incorporates amino acid modifications intended to influence its stability compared with the native GHRH sequence.

Unlike DAC-conjugated CJC-1295, the non-DAC form does not contain a Drug Affinity Complex. This distinction is important when examining its properties and behaviour in experimental systems.

CJC-1295 Without DAC is investigated as a research compound in controlled laboratory studies examining peptide–receptor interactions and associated signalling mechanisms.

This product is supplied exclusively for laboratory research purposes.

Product Specifications:

Research Background:

Growth Hormone-Releasing Hormone Receptor

Growth hormone-releasing hormone (GHRH) is a peptide involved in the regulation of growth hormone secretion.

Its biological activity is mediated through the GHRH receptor, which is expressed on pituitary somatotroph cells.

CJC-1295 Without DAC is a modified GHRH analogue investigated for its interaction with this receptor and its relevance to endocrine signalling research.

Mechanism of Interest:

Experimental research involving GHRH analogues has examined receptor binding, activation and the intracellular signalling pathways associated with receptor stimulation.

CJC-1295 Without DAC is of interest in research investigating how structural modifications to GHRH-related peptides may influence their interaction with the receptor.

Areas of scientific interest include:

• GHRH receptor binding and activation.
• Intracellular signalling associated with GHRH receptor activity.
• Growth hormone-associated endocrine signalling.
• Receptor activation kinetics and peptide interactions.
• Endocrine feedback mechanisms in experimental systems.
• The relationship between peptide structure and receptor activity.

Applications in Research:

CJC-1295 Without DAC may be investigated in laboratory studies involving:

1. GHRH Receptor Research

Investigation of receptor binding, activation and peptide–receptor interactions.

2. Endocrine Signalling

Research examining molecular pathways associated with GHRH receptor activity and endocrine regulation.

3. Growth Hormone-Associated Pathways

Experimental investigations into signalling mechanisms connected with the growth hormone axis.

4. Cellular Signalling Studies

Research examining downstream intracellular signalling and transcriptional responses in appropriate experimental models.

5. Peptide Structure and Activity

Comparative investigations into how structural modifications may influence the properties and receptor interactions of GHRH-related peptides.

6. Comparative GHRH Analogue Research

Use as a research compound in studies comparing non-DAC GHRH analogues with other related peptides under controlled experimental conditions.

Quality & Batch Information:

FabPeptides is committed to providing clear product information and transparent research documentation.

Storage & Handling:

• Protect from moisture and direct light.
• Store under the conditions specified in the applicable batch documentation.
• Follow the relevant stability information when determining appropriate storage conditions.
• Maintain suitable laboratory storage and handling procedures.

Laboratory Handling:

Appropriate laboratory safety procedures should be followed when handling research compounds.

Consult the relevant safety documentation and experimental protocols before handling.

Any preparation or use must remain within the permitted research-only scope of this product.

Important Research-Only Notice:

For in-vitro research use only.

This product is supplied strictly for laboratory research purposes.

It is not intended for human or veterinary use, consumption, injection, administration or diagnostic purposes.

This product is not being offered as a medicine and must not be represented as an authorised treatment or cure for any disease or medical condition.

Purchasers are responsible for ensuring that their intended research activities comply with all applicable laws, regulations and laboratory safety requirements.

FabPeptides

PREMIUM RESEARCH PEPTIDES

FabPeptides is committed to providing clearly presented product information and research-focused materials.

All products are supplied subject to the applicable research-use restrictions and product documentation.